Contact Us

Investor Relations

Peter P. Freundschuh
Chief Financial Officer

Kate Bechtold
Director, Investor Relations & Corporate Communications
UroGen Pharma
Phone: 646-768-9780 x1001
E-mail: investors@urogen.com